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INTRODUCTION:  Cases  of  primary  neuroendocrine  tumors  in  the  liver  combined  with  hepatocellular
carcinoma  are scarce.  Such  cases  could  present  either  as  combined-type  tumor  or collision  type.
PRESENTATION OF  CASE:  A 51-year-old  man  presented  with  a mass  in  the right  hemiliver.  Serum  level
of  alpha-fetoprotein  was  slightly  elevated  (2.3  ng/ml),  with  normal  CA19-9  and  CA125.  The  patient
underwent  right  hepatectomy.  The resected  specimen  showed  a well-deﬁned  and  heterogeneous  gray-
white  to  brown  friable  tumor,  20 cm in  diameter.  Microscopically,  the tumor  consisted  predominantly
of  monotonous  small-  to medium-sized  neoplastic  cells arranged  in  trabeculea  separated  by  sinusoidal
spaces.  Immunohistochemically,  the  tumor  cells  were  strongly  positive  for synaptophysin  and  focally  pos-
itive  for chromogranin-A.  Interestingly,  the tumor  cells  showed  patchy  positive  coarse  granular  staining
of  HerPar-1  involving  about  1%  of the  tumor  cells.  Glypican-3  staining  was  negative.  These  immuno-
histochemical  ﬁndings  supported  the diagnosis  of  combined  high  grade  neuroendocrine  carcinoma  and
hepatocellular  carcinoma.
DISCUSSION: Cases  of  primary  neuroendocrine  tumors  in  the liver  combined  82  with  hepatocellular  carci-
noma  are  scarce.  The  uniqueness  of this  case  lies  in  the fact  that the  neuroendocrine  carcinoma  component
comprised  more  than 99% of the  tumor  area,  and  the minor  hepatocellular  carcinoma  component  was
detected  only  by the  immunohistochemical  staining  for HepPar-1.
CONCLUSION: To  the  best  of our  knowledge,  this  is  the  ﬁrst  case  of  combined  neuroendocrine  carcinoma
and  hepatocellular  carcinoma  in  Egypt.
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. Introduction
Primary hepatic neuroendocrine carcinoma (NEC) is rare and
ts origin is not clearly understood. An admixture of hepatocellu-
ar carcinoma (HCC) and neuroendocrine carcinoma is particularly
are.1 There are 2 types of primary mixed NEC and HCC in the liver.
he combined-type tumor in which both NEC and HCC compo-
ents intermingle with each other and cannot be clearly separated
n the transitional area within a single tumor nodule,2 and the
ollision-type in which the tumor have two histologically distinct
Open access under CC BY-NC-SAumors simultaneously involving the same organ with no transition
etween them.3 We  herein describe a case of combined primary
igh grade NEC and HCC of the liver in which the NEC component
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comprised more than 99% of the tumor area, and only small nests
of HCC were detected only by immunohistochemical staining for
HepPar-1.
2. Case report
A  51-year-old man  presented to our outpatient clinic with a
9-month history of dull aching abdominal pain and a medical his-
tory of hepatitis C. Periodic hepatic ultrasound follow-up showed
a mass in the right hemiliver. A CT scan of the abdomen revealed
a 20 cm × 15 cm mass occupying most of the hemiliver with cys-
tic degeneration and calciﬁcation and multiple dilated collaterals
related to the mass (Fig. 1). The mass was  compressing the right por-
tal vein, yet no invasion detected (Fig. 2). CT volumetry estimated
the residual left hemiliver volume including the middle hepatic
vein to be 1300 cc. Serum level of alpha-fetoprotein (AFP) was
e.slightly elevated (2.3 ng/ml). The patient had normal liver enzymes,
total serum bilirubin of 1.2 mg/dl, serum albumin of 3.3 mg/dl and
INR of 1.1. CA19-9 and CA125 were normal. CT of chest and extra-
hepatic abdomen showed no other lesions.
s Ltd. Open access under CC BY-NC-SA license.
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cig. 1. Arterial phase abdominal CT scan showing large right hemiliver mass with
reas of cystic degeneration. The residual left hemiliver including the middle hepatic
ein being shadowed.
The patient underwent laparotomy through a J shaped inci-
ion (Fig. 3). On exploration the mass was found to be capsulated,
0 cm × 15 cm occupying most of the right hemiliver with multiple
ilated collaterals extending from the mass to the diaphragm and
he hepatic ﬂexure of the colon. No ascites was found. No peritoneal
odules or signiﬁcant lymph nodes. Right hepatectomy was  done.
lood loss was 2500 cc and the patient received 4 units of blood
ntraoperatively due to presence of collaterals and large size of the
ass making mobilization and resection of the right lobe tech-
ically challenging. The patient had an eventless post-operative
ourse and was discharged on the 6th post-operative day.
The  resected specimen measured 20 cm × 15 cm and weighed
500 g. Cut section revealed a well-deﬁned heterogeneous gray-
hite to brown friable mass 7.5 cm in diameter (Fig. 4). The
urrounding liver was non-cirrhotic.
Microscopically, the tumor consisted predominantly of
onotonous small- to medium-sized neoplastic cells arranged in
rabeculea separated by sinusoidal spaces. Tumor cells had round
o oval punctuate nuclei within conspicuous nucleoli and scanty
ytoplasm (Fig. 5A). The tumor was accompanied by wide areas of
Fig. 2. CT portography and hepatic venography showing thFig. 3. Operative photography of the mass showing dilated veins extending from
the mass to the hepatic ﬂexure of the colon.
geographic necrosis with high mitotic rate that ranged between 2
and 20/10 HPF. The whole morphological picture was reminiscent
of high grade NEC. The surrounding liver tissue revealed chronic
hepatitis without cirrhotic changes.
Immunohistochemically, the tumor cells were strongly positive
for synaptophysin (Fig. 5D) and focally positive for chromogranin-
A. Interestingly, the tumor cells showed patchy positive coarse
granular staining for HerPar-1 in less than 1% of tumor cells (Fig. 5B
and C) while Glypican-3staining was  negative. The immunohis-
tochemical ﬁndings supported the diagnosis of combined high
grade NEC and HCC. Follow up period was  short but no recurrence
detected up to 6 months after surgery.
3. Discussion
Cases of primary neuroendocrine tumors in the liver combined
with hepatocellular carcinoma are scarce.2,4 It can present either
as combined-type or collision type.5 We herein describe a case of
combined primary high grade NEC and HCC of the liver in which
the NEC component comprised more than 99% of the tumor area,
and a small nest of HCC was detected only by immunohistochem-
ical staining for HepPar-1. In the case reported by Yang et al.,5
the tumor consisted predominantly of small- to medium-sized
e relation of the mass to the portal and hepatic veins.
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Fig. 4. Cut section of the specimen.
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cig. 5. (A) The tumor was  formed predominantly of small to medium-sized monoto
o  histological evidence of HCC (100×). (B) Less than 1% of the tumor cells showed
f HCC differentiation by H&E (100×). (C) Higher magniﬁcation of Hep-Par-1 immu
eoplastic cells arranged in solid sheets separated by dense
brovascular septa which were reminiscent of NEC. In addition, a
mall island of polygonal tumor cells with abundant eosinophilic
ranular cytoplasm and round nuclei arranged in trabecular
tructures consistent with moderately differentiated HCC were
etected in H&E sections. However, in our case, we  could not ﬁnd
he large polygonal cells with morphological features of HCC in
&E sections. Those cells were highlighted only after immuno-
istochemistry for HepPar-1 which showed patchy cytoplasmic
ranular staining in less than 1% of tumor cells. Interestingly, those
ells were also positive for synaptophysin.cells arranged in trabecular pattern separated by highly vascular stroma. There was
lar cytoplasmic staining for Hep-Par-1. The cells showed no histological evidence
ining. (D) The same cells showed cytoplasmic positive staining for synaptophysin.
Yamaguchi et al.2 reported that some tumor cells of the
HCC in the combined tumor may  be immunoreactive for neu-
roendocrine markers. This supports the postulations of Yang
et al.,5 Ishida et al.6 and Tazi et al.3 that combined NEC–HCC
originates from poorly differentiated HCC that underwent exten-
sive neuroendocrine differentiation. Other studies postulated that
these combined tumors arise from stem cells with divergent
differentiation.7,8
In our case, the surrounding liver tissue was non-cirrhotic which
goes in concordance with most studies that showed that about
20–40% of primary NEC–HCC developed in non-cirrhotic livers.9,10
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n the contrary, pure HCCs are well known to be a direct compli-
ation of liver cirrhosis.
Follow  up of our patient for 6 months revealed no evidence
f recurrence. Despite the fact that patients with pure high grade
euroendocrine carcinomas usually die within few months after
iagnosis,6 reports of some combined NEC–HCC cases showed
onger survival without recurrences for up to 28 months.5 However,
he number of reported NEC–HCC is still rare and further studies are
till needed to substantiate prognosis and treatment of such cases.
To the best of our knowledge, this is the ﬁrst case of combined
EC and HCC in Egypt. The uniqueness of this case lies in the fact
hat the NEC component comprised more than 99% of the tumor
rea, and the minor HCC component was detected only by immuno-
istochemical staining for HepPar-1.
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